Mybulen

Mybulen is a combination analgesic product developed and marketed by Aspen Pharmacare. It contains three active ingredients: ibuprofen (a non-steroidal anti-inflammatory drug), paracetamol (acetaminophen, a non-opioid analgesic and antipyretic), and codeine phosphate (an opioid analgesic). This combination is designed to provide multi-modal pain relief by targeting different pathways: ibuprofen inhibits prostaglandin synthesis via cyclooxygenase (COX) inhibition, paracetamol acts primarily on the central nervous system to elevate the pain threshold, and codeine acts as an agonist at mu-opioid receptors. It is typically used for the relief of mild to moderate pain, including tension headaches, muscular aches, and post-operative pain. The product is part of Aspen's over-the-counter (OTC) business segment in various regional markets.

Brand names

Mybulen